Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Matched Cohort Study of Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy

NCT05523869 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT05523869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05523869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Matched Cohort Study of Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
Lead sponsor
Unity Health Toronto
Phase
Phase 2
Overall status
Recruiting
Start date
February 23, 2023
Completion date
February 28, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative vitreoretinopathy in rhegmatogenous retinal detachment